Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation

Autologous hematopoietic stem cell transplantation using genome-edited cells can become a definitive therapy for hematological and non-hematological disorders with neurological involvement. Proof-of-concept studies using human genome-edited hematopoietic stem cells have been hindered by the low effi...

Full description

Bibliographic Details
Main Authors: Edina Poletto, Pasqualina Colella, Luisa N. Pimentel Vera, Shaukat Khan, Shunji Tomatsu, Guilherme Baldo, Natalia Gomez-Ospina
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
genome editing
CRISPR-Cas9
hematopoietic stem cell
Busulfan
total body irradiation
engraftment
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122000572

Internet

http://www.sciencedirect.com/science/article/pii/S2329050122000572

Similar Items